Celyad Oncology SA: Celyad Oncology Announces June 2021 Conference Schedule
Regulatory News:
Celyad Oncology SA (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD) (Euronext Nasdaq: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, today announced that the company plans to participate at the following conferences in June 2021:
Jefferies Virtual Healthcare Conference
Presentation date: Tuesday, June 1, 2021
Time: 11:00 a.m. EST 5:00 p.m. CET
Presenter: Filippo Petti, CEO
Events section of the Celyad Oncology website.
William Blair Company Annual Growth Stock Conference
Dates: Tuesday, June 1 Thursday, June 3, 2021
Presentation date: Wednesday, June 2, 2021